Shannon Lam

Shannon focuses on developing and implementing strong patent strategies to advance her clients’ business goals and objectives.  She advises on global patent portfolio management, IP due diligence, competitive landscape analysis, IP agreements, and USPTO post-grant proceedings.  Whether a client is seeking investment, moving toward acquisition, or growing an existing portfolio, Shannon’s strategic guidance and counseling align with the objectives of a company’s life cycle at any stage.

Shannon’s clients range from fast-growth, emerging companies to major corporations in a variety of industries, including medical device, food & beverage, and consumer products.

Within the medical device industry, Shannon has worked extensively with cardiovascular, orthopedic, and ophthalmic technologies.  She has been involved in the intellectual property strategy and acquisitions of IDEV Technologies (acquired by Abbott), AccessClosure (acquired by Cardinal Health), Claret Medical (acquired by Boston Scientific), Tornier/Wright Medical (acquired by Stryker), AcuFocus (acquired by Bausch + Lomb), and HealthpointCapital (acquisition of SteriCUBE).  Shannon has also represented medical device companies in IPR proceedings before the Patent Trial and Appeal Board.

In addition to her depth of experience in medical device, Shannon has procured patents for family-owned businesses and managed global patent portfolios for Fortune 500 companies in the food & beverage and consumer products industries.  She provides IP counseling on acquisitions and agreements in which IP assets are central to the transactions.

Shannon was recently named “Rising Star” in the Legal Media Group (LMG) “LMG Life Sciences” Guide (2024) and was recognized in the “Best Lawyers 2025 Guide: Ones to Watch” for Intellectual Property Law and Patent Law in Best Lawyers in America.

Shannon is Chair of Knobbe Martens Mentor Committee and previously served as Co-Chair the firm’s Women Associates Advisory Committee.